Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Third Wave s Invader Occupies Microarray Platform

NEW YORK, Aug. 21 – Third Wave Technologies and researchers from two academic centers in the US have applied the company’s Invader SNP-detection technology to a microarray platform, Third Wave said on Tuesday.

Applying the Invader technology onto a bead, chip or other microarray format will allow Third Wave to market to scientists performing highly multiplexed analyses, the company said in a statement.

The application, perfected by Third Wave and researchers at Northwestern University and the University of Wisconsin-Madison and detailed in the current issue of Nucleic Acids Research Methods Online , “extends the scalability and market potential of the platform,” Lance Fors, Third Wave’s chairman and CEO, said in the statement.

A spokesman for Third Wave said that it took the company and its university partners roughly one year to show that the Invader technology can be applied to a microarray platform. Third Wave plans to report its findings at the 51st annual meeting of the American Society of Human Genetics in October, he added. 

He could not say when the technology would be ready for commercialization.

Last month, Third Wave said that sales of its Invader SNP analysis system boosted second-quarter revenues to $8.7 million from $800,000 in the year-ago period. 

Based on demand for its Invader DNA and RNA products, the company said it expects revenues to reach at least $6 million in the third quarter and $32 million for the year. 

Third Wave, based in Madison, Wisc., also said in July that it had established an internal bioinformatics department that will annotate genome sequences targeted by the Invader system. 

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.